Literature DB >> 22274132

D-ribose in glycation and protein aggregation.

Yan Wei1, Chan Shuai Han, Jun Zhou, Ying Liu, Lan Chen, Rong Qiao He.   

Abstract

BACKGROUND: D-ribose is a naturally occurring pentose monosaccharide present in all living cells and their microenvironments and is a key component of numerous biomolecules involved in many important metabolic pathways. It also participates in the glycation of proteins producing advanced glycation end products (AGEs) that lead to cell dysfunction and death. As recent studies show, ribosylation, a rapid process, causes protein aggregation in vitro and in vivo. SCOPE OF REVIEW: This review summarizes the relationship between ribosylation, protein aggregation, cell death and cognitive impairments. MAJOR
CONCLUSION: D-ribose is active in glycation and induces protein aggregation, rapidly producing AGEs in vitro and in vivo. GENERAL SIGNIFICANCE: Ribosylation, leading to the production of significant amounts of AGEs both extracellularly and intracellularly, may be involved in cell dysfunction and subsequent cognitive impairments. This review may be a useful reference for studies on the pharmacokinetics of D-ribose action.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274132     DOI: 10.1016/j.bbagen.2012.01.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

Review 1.  Glycation of antibodies: Modification, methods and potential effects on biological functions.

Authors:  Bingchuan Wei; Kelsey Berning; Cynthia Quan; Yonghua Taylor Zhang
Journal:  MAbs       Date:  2017-03-08       Impact factor: 5.857

2.  Modulated Protein Binding Ability of Anti-Diabetic Drugs in Presence of Monodispersed Gold Nanoparticles and its Inhibitory Potential towards Advanced Glycated End (AGE) Product Formation.

Authors:  Imocha Rajkumar Singh; Sivaprasad Mitra
Journal:  J Fluoresc       Date:  2020-01-10       Impact factor: 2.217

Review 3.  D-ribose and pathogenesis of Alzheimer's disease.

Authors:  Mehjbeen Javed; Md Irshad Ahmad; Hina Javed; Sufia Naseem
Journal:  Mol Biol Rep       Date:  2020-01-13       Impact factor: 2.316

4.  Ribosylation of bovine serum albumin induces ROS accumulation and cell death in cancer line (MCF-7).

Authors:  Mohd Shahnawaz Khan; Sourabh Dwivedi; Medha Priyadarshini; Shams Tabrez; Maqsood Ahmed Siddiqui; Haseeb Jagirdar; Abdulrahman M Al-Senaidy; Abdulaziz A Al-Khedhairy; Javed Musarrat
Journal:  Eur Biophys J       Date:  2013-11-12       Impact factor: 1.733

5.  Detection of Circulating Auto-Antibodies Against Ribosylated-LDL in Diabetes Patients.

Authors:  Firoz Akhter; M Salman Khan; Mohammad Faisal; Abdulrahman A Alatar; Saheem Ahmad
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

6.  An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation.

Authors:  Igor Maksimovic; Qingfei Zheng; Marissa N Trujillo; James J Galligan; Yael David
Journal:  J Am Chem Soc       Date:  2020-05-22       Impact factor: 15.419

7.  Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose.

Authors:  Grażyna E Sroga; Alankrita Siddula; Deepak Vashishth
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

8.  Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII.

Authors:  Yan Wei; Chanshuai Han; Yujing Wang; Beibei Wu; Tao Su; Ying Liu; Rongqiao He
Journal:  Aging Cell       Date:  2015-06-11       Impact factor: 9.304

9.  Prolonged glycation of hen egg white lysozyme generates non amyloidal structures.

Authors:  Sudeshna Ghosh; Nitin Kumar Pandey; Atanu Singha Roy; Debi Ranjan Tripathy; Amit Kumar Dinda; Swagata Dasgupta
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

10.  D-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation.

Authors:  C Han; Y Lu; Y Wei; B Wu; Y Liu; R He
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.